a short while ago i spoke to lars martin greiner an associate partner at hamburg part consultancy a maritime advisory firm and asked asked him just how much of the hit to global trade the every given slice canal incident represents it's the major trading route especially between europe and the end asia this is the key lifeline it's where 80 percent of the cargo container is cargo moving between the $2.00 to $2.00 areas is it's it's very very important and it couldn't have come at a worse time. coverts had a major effect on shipping like everything else we've got major disruption in contain a flows around the world in some ports we've got major major deficits of containers you can't get the containers and other quote in other places containers are piling up because they just can't get them out of the port fast enough because of covert so this is just going to add to that. so it really should couldn't come at all at a worse time for us right definitely already a troubled time for the shipping industry but say you are sick and you're blocked from your plan passed by the ever given what to do. w

in frankfurt and lars martin greiner in hamburg thanks to both of you. and on to some of the other global business stories making news the history of the side billy billy sank 6 percent on his 1st day of trading in hong kong as did shares in the chinese search engine baidu stave units in hong kong last week chinese take shares are suffering after years regulators announced plans to force firms from china to observe u.s. auto. german exporters are increasingly optimistic that they'll benefit from economic recovery in asia and the united states a survey by the economic institute showed their expectations in march rise to the highest value since january 20th 11 it was optimism in nearly all sectors. your leaders and representatives of covert 19 vaccine makers are meeting today and it's going to be a heated discussion as the e.u. grapples with a shortage of doses the bloc last week decided to restrict the export of vaccines made within the block patents are also likely to be on the agenda. for lucrative patients restricting the global vaccine rollout not nec